As the uses for artificial intelligence grow within rheumatology, so do the benefits and the concerns about the technology. In a session at ACR Convergence 2025, two experts discuss the research on both sides of the debate.
The ASTP/ONC’s recently updated United States Core Data for Interoperability Version 6 includes new data elements and applicable standards to support the provision of precision medicine and better patient care across the healthcare system.
In comments to the National Association of Insurance Commissioners, the ACR outlined several recommendations for a proposed state model law addressing the use of artificial intelligence in the insurance industry.
Clinical researchers who perform laboratory testing are required to switch to email notifications before March 1, 2026, to continue receiving fee coupons and certificates. After that date, CLIA paper fee coupons and certificates will no longer be available.
Virtual reality technology may be a unique and immersive avenue for educating patients on rheumatic conditions and their treatments, with the potential to enable more informed decision making and improve care.
Disease detection, access to care and remote patient monitoring are just a few areas in which AI is expected to aid rheumatology, but there will still be room for the human touch.
The proposed changes aim to address modern breach and cybersecurity risks to electronic protected health information and common deficiencies observed by the HHS in Security Rule compliance investigations.